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a b s t r a c t
Mutations in the Aristaless related homeodomain transcription factor (ARX) are associated with a diverse
set of X-linked mental retardation and epilepsy syndromes in humans. Although most studies have been
focused on its function in the forebrain, ARX is also expressed in other regions of the developing nervous
system including the ﬂoor plate (FP) of the spinal cord where its function is incompletely understood. To
investigate the role of Arx in the FP, we performed gain-of-function studies in the chick using in ovo
electroporation, and loss-of-function studies in Arx-deﬁcient mice. We have found that Arx, in
conjunction with FoxA2, directly induces Sonic hedgehog (Shh) expression through binding to a Shh
ﬂoor plate enhancer (SFPE2). We also observed that FoxA2 induces Arx through its transcriptional
activation domain whereas Nkx2.2, induced by Shh, abolishes this induction. Our data support a
feedback loop model for Arx function; through interactions with FoxA2, Arx positively regulates Shh
expression in the FP, and Shh signaling in turn activates Nkx2.2, which suppresses Arx expression.
Furthermore, our data are evidence that Arx plays a role as a context dependent transcriptional activator,
rather than a primary inducer of Shh expression, potentially explaining how mutations in ARX are
associated with diverse, and often subtle, defects.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Cell type speciﬁcation is a dynamic process dependent on cell
extrinsic and intrinsic signaling programs. The developing spinal
cord serves as an excellent model system to study cell type
speciﬁcation. Many studies over past decades have deduced that
morphogenic gradients formed by several signaling molecules (e.g.
sonic hedgehog and retinoic acid) initiate intrinsic transcription
networks enabling ﬁrst the speciﬁcation of distinct progenitor
cells and subsequently maintaining their identity (Davidson, 2002;
Jessell, 2000). Understanding how the various factors in this
process interact is crucial to unraveling the mechanisms under-
lying cell fate determination.
Sonic hedgehog (Shh) is a secreted protein with well-
established roles in cell fate speciﬁcation in the ventral spinal
cord. It is ﬁrst expressed in the mesodermally derived notochord
and subsequently in the ventral midline of the developing neural
tube (i.e., ﬂoor plate, FP). When Shh binds the transmembrane
receptor, Patched (Ptc), it releases the inhibition of Smoothened
(Smo), which then translocates to the cytoplasm and initiates a
signaling cascade that results in the nuclear translocation of Gli
(Gli1-3) transcription factors. Gli transcription factors bind speciﬁc
cis-elements (GBSs; Gli binding sites) of downstream target genes
to activate or repress their transcription (Briscoe et al., 2000;
Dessaud et al., 2008). It is known that Shh stabilizes full-length
Gli2 and Gli3 proteins in their activator forms (GliA); in the
absence of ligand these bi-functional proteins undergo proteolysis
and change to repressor forms (GliR) (Dessaud et al., 2008;
B. Wang et al., 2000).
Shh signaling functions in a gradient to establish unique cell
fates along the dorsal ventral axis of the developing spinal cord. In
response to this morphogen gradient, transcription factors in
responding cells are either induced or repressed to establish the
p0, p1, p2, pMN, p3, and FP domains. In turn, each progenitor
domain gives rise to a distinct neuronal (V3, MN, V2, V1 and V0),
and non-neuronal (FP) subtypes (Dessaud et al., 2008; Jessell,
2000). Ventral neural tube development is not only dependent on
its spatial concentration gradient of Shh, but also the timing and
duration of the signaling (Chamberlain et al., 2008; Dessaud et al.,
2007, 2008). Increasing levels and durations of Shh signaling
direct progenitors to adopt progressively more ventral identities
(Chamberlain et al., 2008; Dessaud et al., 2007, 2008). Further-
more, the interpretation of the Shh morphogen gradient into an
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intrinsic transcriptional network, rather than Shh gradient itself,
has been shown to be responsible for differential spatial and
temporal gene expression (Balaskas et al., 2012). Moreover, iden-
tiﬁcation and characterization of the cis-regulatory modules
(CRMs) of target genes operating downstream of Shh signaling
have clariﬁed how different cells interpret their Shh signaling
depending on their relative location in relation to the signaling
source (Oosterveen et al., 2012; Peterson et al., 2012).
Speciﬁcation of the most ventral cell type, the non-neuronal FP
cells, is thought to be a sequential process. Initially, the presump-
tive FP cells, in response to notochord-derived Shh, express a set of
transcription factors (e.g. FoxA2, Nkx2.2 and Nkx6.1) that are also
expressed in adjacent progenitor cells (p3). Later the developing
FP cells also begin expressing Shh and Arx, whereas Nkx2.2
expression is down-regulated and no longer detected in the
presumptive FP but continues to be expressed in the adjacent p3
domain. Unlike other ventral neuronal subtypes, where high levels
and longer duration of Shh signaling predict more ventral iden-
tities, FP speciﬁcation involves a biphasic response to Shh signal-
ing. Initially, high levels of Shh signaling are required for FP
speciﬁcation (Ribes et al., 2010); however, maintenance of the FP
is Shh signaling independent, although Shh continues to be
expressed by FP cells. If Shh signaling is maintained during this
time instead of down-regulated, FP cells convert their identity to
ventral neural progenitors (Ribes et al., 2010).
Despite the down-regulation of Shh signaling in FP cells, Shh
itself is not down-regulated, suggesting that the FP cells must
maintain adequate levels of Shh production for the generation of
other ventral cell types, and for functions such as a commissural
axon chemoattraction (Bourikas et al., 2005). Paradoxically, the
transcription factor FoxA2 is responsible for inducing Shh expres-
sion, while it simultaneously down-regulates Shh signaling to
maintain FP identity and inhibit p3 fate.
Two enhancer regions have been identiﬁed in the regulatory
regions of Shh that are responsible for spinal cord FP speciﬁc
expression: Shh Floor Plate Enhancer 1 and 2 (SFPE1 and 2)
(Epstein et al., 1999; Jeong and Epstein, 2003). SFPE1 activity is
controlled in a FoxA2-independent manner. In contrast, SFPE2
activity is regulated by two elements, a Homeobox transcription
factor Binding Site (HBS) and a FoxA2 binding site. Both are required
for the full activity in the FP (Epstein et al., 1999; Jeong and Epstein,
2003). To date the homeodomain transcription factor(s) that binds to
SFPE2 has not been identiﬁed.
The aristaless related homeodomain transcription factor (Arx) is
the vertebrate homolog of Drosophila Aristaless (Miura et al.,
1997). It is expressed in the developing brain including the
cerebral cortex, basal ganglia, hypothalamus, thalamus, midbrain,
and hindbrain (Colombo et al., 2004; Miura et al., 1997). Its
expression is ﬁrst detected at the 3 somite stage (E8) in mouse
embryos and it persists through early postnatal life (Colombo
et al., 2004). Mutations in ARX have been linked to morphological
brain anomalies as well as multiple neurologic deﬁcits in patients
(Friocourt and Parnavelas, 2010; Kato et al., 2004; Kitamura et al.,
2002; Mégarbané et al., 2011; Olivetti and Noebels, 2012; Sherr,
2003; Shoubridge et al., 2010; Strømme et al., 2002). Arx-deﬁcient
mice have intermediate progenitor cell proliferation defects in the
forebrain resulting in small brains (Colasante et al., 2013; Kitamura
et al., 2002). They also show aberrant migration and differentiation
of interneurons in the ganglionic eminence and neocortex (Fulp
et al., 2008; Kitamura et al., 2002; Marsh et al., 2009; Nasrallah
et al., 2012). Furthermore, loss of Arx in mice, through conditional
gene abrogation, results in structural brain anomalies, epilepsy,
and neurocognitive phenotypes (Colasante et al., 2013; Fulp et al.,
2008; Kitamura et al., 2002; Marsh et al., 2009).
Arx is also expressed in FP cells of the developing spinal cord;
however its function in the FP has not been explored. Based on the
observations that (1) Arx is expressed in FP cells during the period
of Shh induction and (2) it is a homeodomain transcription factor,
we hypothesized that Arx binds to the HBS of SFPE2 and induces
Shh expression. To test our hypothesis, we performed both gain-of-
function and loss-of-function experiments using the chick embryo
and Arx deﬁcient mice. We ﬁnd Arx indeed binds the SFPE2 site
and induces Shh expression in the presence of FoxA2. Furthermore,
our data demonstrate that FoxA2 induces Shh via its activation
domain, while Nkx2.2 represses FoxA2-induced Arx expression.
These results support a model where Arx and FoxA2 participate in
a feedback loop with Shh signaling, establishing a robust method
to regulate the dynamic expression of Shh required for its multiple
functions during spinal cord development.
Materials and methods
Mice
Arx mutant mice (Fulp et al., 2008) were bred and maintained
on C57Bl/6 background in according with an approved IACUC
protocol at the Children's Hospital of Philadelphia and Brigham
and Women's Hospital/Harvard Medical School. Arx /y mouse
embryos were generated by mating ArxF/þ with EIIacre male (The
Jackson Laboratory stock no. 003724). All genotypings were
performed as previously described (Fulp et al., 2008).
DNA constructs
Arx, FoxA2, Nkx2.2 (human sequence for NKX2.2 was used but is
referred throughout as Nkx2.2) and each deletion mutant, used for in
ovo electroporation, were cloned into the pCIG vector (Megason and
McMahon, 2002) that expresses eGFP under IRES, after PCR-
ampliﬁcation with the oligonucleotides as following: ArxF (50-CG
GAATTCCACCATGAGCAATCAGTACCAGGAAGAG-30), Arx61F (50-CG
GAATTCCACCATGGAAAAAGCCATGCAAGGCTCCCCC-30), Arx220F (50-
CGGAATTCCACCATGGGCGCCGAGGACGACGAGG-30), Arx471mycR (50-
ACTTCAACGCGTCTACAGATCTTCTTCAGAAATAAGTTTTTGTTCCGCTGCT
CCTAGAAAAGTGCTCAGACC-30), ArxmycR (50-ACTTCAACGCGTCGAGC-
TACAGATCTTCTTCAGAAATAAGTTTTTGTTCGCACACCTCCTTCCCCGTGCT
G-30), FoxA2FLAGF (50-CGGAATTCCACCATGGATTACAAGGATGACGAC-
GATAAGCTGGGAGCCGTGAAGATGGAA-30), FoxA2R (50-ACCGACGCGTT-
TAGGATGAGTTCATAATAGGCCTGGAGTACACTC-30), FoxA2F52 (50-CGG
AATTCCACCATGGATTACAAGGATGACGACGATAAGGGCGGCGGTTCCGG-
CAACAT –30), FoxA2R-418 (50-AACCGACGCGTTTAGGAACCATAGCCCCCT
GGGTAGTGC-30), FoxA2D372-383F (50-CCACCTGAAGCCCGAGCACCAT-
TACTCGTCCGAGCAGCAACATCACCA-30), Nkx2.2F (50-CGGAATTCCAC-
CATGGATTACAAGGATGACGACGATAAGATGTCGCTGACCAACACAAAGA
CGG-30), Nkx2.2R (50-AACCGACGCGTTCACCAAGTCCACTGCTGGGCCT-
30), Nkx2.2F113 (50-CGGAATTCCACCATGGATTACAAGGATGACGACGAT-
AAGGACAATGACAAGGAGACCCCGGGC-30) and Nkx2.2R187 (50-AA-
CCGACGCGTTCACCGGGCGCGCTTCATCTTGTAG-30). Arx MT is R3-
32H, which does not bind to DNA due to mutation in homeodomain
of Arx (Cho et al., 2012). The FoxA2 and Nkx2.2 constructs include a
FLAG-tag embedded in the 50 end of the oligonucleotide sequence. The
FoxA2ΔA (52-418) deletion construct lacks the transcription activation
domain (Pani et al., 1992). The FoxA2ΔI, internal deletion mutant
which excludes amino acid 372–387 (TLE/Groucho binding site), was
cloned into EcoRI and MluI of pCIG vector as described previously (J.C.
Wang et al., 2000). Nkx2.2HD (aa113–187) (dominant negative mutant
which contains only homeodomain) was constructed into pCIG as
previously described (Watada et al., 2000). The PtcΔloop2, SmoM2, and
ΔN-Gli3 constructs were all previously described (Lei et al., 2004; Lek
et al., 2010; Tenzen et al., 2006). The deleted Arx DNA fragments, used
for immunoprecipitation experiment, were subcloned into both EcoRI
and XbaI digested pM vector (Clontech) after PCR ampliﬁcation; ArxF
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(50-CGGAATTCATGAGCAATCAGTACCAGGAAGAGG-30), Arx221F (50-CG
GAATTCGGCGCCGAGGACGACGAGGAGGAG-30), Arx321F (50-CGGAATT
CTCGGAGGAGGGGCTGCTGAAGCGC-30), Arx471F (50-CGGAATTCGCGG
TGTTCCGCCACCCAGCCTTC-30), Arx220R (50-GCCCTCTAGACGTGCCAC-
CACCCGCCGCGGGGGC-30), Arx320R (50-GCCCTCTAGAGTCGCTGCCGGC
CGACAGGCACACG -30), Arx470R (50-GCCCTCTAGATGCTCCTAGAAAAGT
GCTCAGACCC-30) and ArxR (50-GCCCTCTAGATTAGCACACCTCCTTCCC
CGTGCTG-30). For generation of the full length Arx protein in mam-
malian expression system, the FLAG-tagged Arx PCR product was
subcloned into pcDNA3.1-d-TOPO (Invitrogen) with ArxFLAGF (50-
CACCATGAGCAATCAGTACCAGGAAGAGGGC-30) and ArxFLAGR (50-
TTACTTATCGTCGTCATCCTTGTAATCGCACACCTCCTTCCCCGTGCTG-30).
In ovo electroporation
Electroporation was performed as previously described
(Briscoe et al., 2000; Lim et al., 2005). DNA was injected into the
neural tube of Hamburger–Hamilton stage 10–12 (HH10–HH12)
chick embryos at concentrations of 5.0 μg/μl in TE with 50 ng/μl
Fast Green. For co-electroporation of low FoxA2 and ArxWT or
ArxMT, FoxA2 expression construct was used in one tenth of Arx
DNA. For all other co-electroporation, DNAs were mixed at 1:1
ratio. Approximately 48 h following electroporation, embryos
were harvested and ﬁxed in 4% paraformaldehyde for subsequent
immunostaining.
Immunohistochemistry
All immunohistochemistry was performed as previously
reported (Lim et al., 2005). Brieﬂy, embryos were collected, ﬁxed
overnight in cold 4% paraformaldehyde, washed at 4 1C in PBS,
cryoprotected overnight at 4 1C in PBS containing 30% sucrose, and
frozen in OCT (Tissue-Tek). Twelve-micrometer sections at the
spinal cord or hindbrain level were then cut for subsequent
immunostaining. The primary antibodies used include rabbit
anti-FoxA2 (1:20, Epitomics), mouse anti-Shh (1:2000, Sigma),
mouse anti-Shh (1:10, DSHB), rabbit anti-Shh (1:200, Santa Cruz
Biotechnology), mouse anti-Nkx2.2 (1:5, DSHB), mouse anti-Pax7
(1:20, DSHB), rabbit anti-Nkx6.1 (1:5, DSHB), rabbit anti-Olig2
(1:5000, Epitomics, rabbit), mouse anti-Nkx2.2 (1:5, DSHB), mouse
anti-Isl1/2 (1:20, DSHB), and rabbit anti-Arx (1:200, Kitamura
et al., 2002). Nuclei were visualized with DAPI (1:30,000, Invitro-
gen) staining. Secondary antibodies conjugated with Alexa 488,
568, or 633 (1:200, Invitrogen) were utilized for visualization on a
Leica DMR microscope equipped with epiﬂourescence and a Leica
DFC345 FX camera. DAB and ABC kits (Vector Lab) were used for
Shh, Alcam and Olig2 immunostaining. A minimum of 5 sections,
from at least three embryos of each genotype, were examined in
the mouse studies. The number of Olig2-positve cell was counted
manually (E11.5) or automatically (E14.5) using Particle Analysis in
ImageJ (Fiji).
Electromobility shift assay (EMSA), chromatin immunoprecipitation
(ChIP), and immunoprecipitation (IP)
EMSA was performed as previously described (Cho et al., 2012).
The full length Arx protein was expressed in HEK293 transfected
with pcDNA3.1–FLAG–Arx and puriﬁed with FLAG-beads (Sigma)
in the TNE buffer (20 mM Tris–HCl [pH 7.4], 150 mM, NaCl, 0.5%
Triton X-100, 5% glycerol). The puriﬁed Arx protein was applied to
5% polyacrylamide gel with double stranded oligonucleotides,
SFPE2F (50-CTTTATTGGATTTTAATTAGAAAATCCACACA-30)/SFPE2R
(50-TGTGTGGATTTTCTAATTAAAATCCAATAAAG-30) and mSFRP2F
(50-CTTTATTGGATTTTCCTTAGAAAATCCACACA-30)/mSFRP2R (50-T-
GTGTGGATTTTCTAAGGAAAATCCAATAAAG) labeled by biotin (Inte-
grated DNA Technologies). To detect the DNA/Arx complex, we
utilized the LightShift Chemiluminescent EMSA kit (Thermo
Scientiﬁc).
For ChIP assays, E9.5 mouse spinal cord tissues were used. After
dissection and dissociation, the spinal cord tissues were ﬁxed with
1% formaldehyde for 10 min at room temperature on a rotating
rocker. ChIP was performed following the protocol for the EZ ChIP
Immunoprecipitation Kit (EMD Millipore) using a rabbit anti-Arx
and control rabbit antibody (Invitrogen). Primers spanning SFPE2
within intron2 of Shh gene, qSFPE2-R1 (50-CCCGAGACTTGTGTGGA
TTT-30) and qSFPE2-R2 (50-TCCGAGGCTGTCTCCTATTTA-30), primers
1 kb away from upstream of SFPE2, -1kbF (50-CGTAA-
GTCCTTCACCAGCTT-30) and -1kbR (50-CTCAACACCTGGTCTTT-
CTCTC-30) were used for real time PCR of the immunoprecipitated
DNAwith SsoAdvanced Universal Supermix (Bio-rad). The primers,
negR (5-ATGGTTGCCACTGGGGATCT-30) and negR (50-TGCCAAAG-
CCTAGGGGAAGA-30) ﬂanking genomic region between Gapdh and
Cnap1, were used for negative control.
The immunoprecipitation experiment was performed as pre-
viously described with only slight modiﬁcations (Nasrallah et al.,
2012). After co-transfected with FLAG-FoxA2 and Arx-Myc,
HEK293T cells were lysed with TNE buffer (20 mM Tris–HCl [pH
7.4], 150 mM, NaCl, 0.5% Triton X-100, 5% glycerol) containing a
protease inhibitor cocktail (Roche Applied Science). Anti-FLAG
(M2) monoclonal antibody (Sigma) or anti-Myc antibody (Cell
Signaling technology) was used for immunoprecipitation. For
preclearance, lysates were incubated with protein G-conjugated
beads (Invitrogen). Each primary antibody (2 μg) deﬁned by the
individual experiment was added, incubated at 4 1C for 1 h, and
then incubated with the protein G-conjugated beads for an
additional hour. The beads were washed with TNE buffer twice
and with TNE buffer containing 500 mM NaCl twice, followed by a
ﬁnal wash with TNE buffer. Bound proteins were eluted using
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer. To detect the associated protein in the
immunoprecipitate, SDS-PAGE followed by Western blotting was
performed using anti-Arx, anti-FLAG (M2, 1/500; Sigma) and anti-
GAL4 (Clontech) antibody.
Results
Arx expression in the ﬂoor plate
To establish the developmental time course of Arx expression in
the developing chick spinal cord, we took advantage of the normal
rostral to caudal gradient of neural tube development. In HH10
chick embryos, the neural tube is rostrally closed; however, a small
segment remains open at the most caudal end. Arx is expressed in
the rostral neural tube (hindbrain and thoracic level of the spinal
cord) but it is not detected in the developmentally younger caudal
neural tube (lumbar level of the spinal cord) (Fig. 1). Arx expres-
sion is restricted to the ventral midline where it overlaps with
FoxA2, although the FoxA2 expressing domain does extend to
several cell bodies beyond that of Arx. In contrast, FoxA2, Nkx2.2
and Nkx6.1 are ventrally expressed along the entire rostral–caudal
neural axis (Fig. 1). As expected, Nkx2.2, and to a lesser extent
Nkx6.1, are largely excluded from the presumptive FP at the more
rostral levels of the neural tube; however both are expressed just
lateral to the Arx expressing domain (Fig. 1). The co-expression of
FoxA2, Nkx2.2 and Nkx6.1 in the presumptive FP at the lumbar
neural tube suggests that at the early stage, the FP identity is
mixed with p3 identity, since the presumptive FP cells initially
express markers that are shared with p3 and pMN progenitors
such as Nkx2.2 and Nkx6.1, respectively. This data is consistent
with the previous report of Shh expression in the FP (Ribes et al.,
2010). Furthermore, we ﬁnd Shh expression coincides with that for
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Fig. 1. Cross-sections of embryonic chick neural tube (HH10) showing Arx, Nkx2.2, Nkx6.1, FoxA2 and Shh expression in the hindbrain (HB) and spinal cord (SC). The colored
letters on the left side box indicate the antibodies used for immunohistochemistry. HB (hindbrain), thoracic SC, and lumber SC indicate the level of each section. Scale bar in
the upper left panel is 50 μm for all images.
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Fig. 2. Ectopic expression of Arx induces Shh and Shh-downstream genes in the presence of FoxA2. (A) In ovo electroporation (EP) of Arx to the ventral or dorsal spinal cord
analyzed for Nkx2.2, Nkx6.1, FoxA2, and Shh expression via immunostaining. Arx EP to the ventral neural tube induces FoxA2, Nkx2.2, Nkx6.1 and Shh (bottom panel), while
dorsally targeted Arx does not (top panel). The electroporated plasmid expresses Arx and GFP, thus the presence of GFP reports the location of ectopic Arx expression. Boxed
areas labeled 1–4 corresponded to high power images at bottom of (A). (B) Co-electroporation of low level of FoxA2with ArxWT (wild type) (1:10 ratio in DNA concentration)
induces Shh cell non-autonomously, even in the dorsal neural tube, whereas co-electroporations of low level of FoxA2 with Arx MT (non-DNA bound homeodomain mutant;
R332H) or mock DNA do not. Arrows in (A) and (B) indicate the ectopic induction of Shh or Shh downstream target genes. Scale bars in (A) and (B) are 50 μm.
G. Cho et al. / Developmental Biology 393 (2014) 137–148140
Arx (Fig. 1). These results conﬁrm that Arx is expressed late in
ventral midline development, but in the deﬁnitive FP when p3
markers, such as Nkx2.2, are no longer expressed.
Arx positively regulates ﬂoor plate Shh induction in the presence of
FoxA2
Arx expression in the FP coincides with the strong induction of
Shh in these same cells (Fig. 1) (Ribes et al., 2010). Thus, we
postulated that Arx might regulate Shh transcription in the FP. To
test this assumption we electroporated an Arx expression con-
struct into chick neural tubes and assayed for changes in gene
expression. Targeting Arx to the dorsal neuroepithelium failed to
induce Shh or the Shh downstream genes, Nkx2.2 and Nkx6.1
(Fig. 2A). In contrast, when Arx was targeted to the ventral spinal
cord, Shh as well as Shh downstream genes were induced (Fig. 2A).
These data suggest that Arx can induce Shh expression only in the
presence of other ventral factor(s). Given that FoxA2 is also
expressed in the FP and known to induce Shh (Ribes et al.,
2010), we next tested whether FoxA2 might be the cooperating
factor to function with Arx. When an Arx expression construct
(WT) was co-electroporated in the dorsal spinal cord with low
levels of a FoxA2 construct, the Shh gene was strongly induced in
cell autonomous manner (Fig. 2B). However, when a mutant Arx
construct (MT) that harbors the R332H mutation in the home-
odomain leading to loss of DNA binding activity (Cho et al., 2012)
was co-electroporated with low levels of FoxA2, Shh was no longer
induced (Fig. 2B). In contrast, a low level of FoxA2 was not able to
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Fig. 3. Arx binds to the HBS within Shh enhancer (SFPE2) and interacts with FoxA2. (A) EMSA with the full-length Arx protein puriﬁed from transfected HEK293T cells and
SFPE2 DNA fragments shows the DNA/protein complex (lane 2). The DNA/protein complex was reduced in the presence of unlabeled SFPE2 DNA competitor (lane 3).
However, when the SFPE2 is mutated in the HBS (mSFPE2), it can no longer bind to Arx (lanes 4–6). (B) ChIP assay using developing spinal cord with either an anti-Arx
antibody or control IgG. Enrichment of the PCR product in the immmunoprecipitated sample with anti-Arx antibody was observed with three primer sets (one 1 kb upstream
region of SFPE2, a second in SFPE2 and the third a negative control which is in GAPDH locus) compared to control. (Note: ChIP was performed onwhole spinal cords, of which
less than 0.01% is FP.) Error bars correspond to SD (*, p¼0.04, two–tailed, unpaired t-test). (C) Arx directly interacts with FoxA2. HEK293T cells transfected with Arx-Myc and
FoxA2-FLAG were used for immunoprecipitation (IP) experiments. IP with FLAG (FoxA2) antibody conﬁrmed an interaction with Arx (Western blot with anti-Arx antibody).
(D) Arx interacts with FoxA2 through its homeodomain. HEK293T cells transfected with a series of Arx deletion mutants (aa1–220, 221–321, 321–470 and 471–564
conjugated to Gal4DB) with FLAG-FoxA2, were used for IP. An Arx construct containing the homeodomain, Gal4DB-321-470 (red), was co-immunoprecipitated with FoxA2,
whereas other constructs were not. The arrows identify the full-length protein of each mutant.
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induce Shh expression or only did so slightly. Together these
ﬁndings suggest Arx collaborates with FoxA2 to induce Shh.
Arx can interact with FoxA2 and bind to the Shh enhancer, SFPE2
We next asked whether Arx modulates Shh expression through
direct binding to its genomic regulatory sequence. Two enhancer
regions have been reported for the FP expression of Shh: Shh Floor
Plate Enhancer1 (SFPE1) and SFPE2 (Epstein et al., 1999; Jeong and
Epstein, 2003). SFPE2 includes two sequence elements crucial for
Shh induction; a homeodomain binding site (HBS) and a FoxA2
binding site separated by 51 base pairs (Jeong and Epstein, 2003).
While FoxA2 binding in SFPE2 has been established, the home-
odomain transcription factor(s) that binds to this HBS is unknown.
We hypothesized that Arx, a paired-like homeodomain transcrip-
tion factor, could bind to this cis-element and activate Shh
expression in cooperation with FoxA2 in developing neural tube.
In order to test this hypothesis, we performed electromobility shift
assay (EMSA) and chromatin immunoprecipitation (ChIP). The
Arx (Cho et al., 2012) bound directly to the HBS of SFPE2 and
this binding exhibited speciﬁcity by cold competition, whereas a
mutated SFPE2 fragment did not form a complex with Arx
(Fig. 3A). We veriﬁed this binding of Arx to the HBS in vivo by
ChIP using embryonic spinal cords from E10.5 mouse and anti-Arx
antibody. Our ChIP data conﬁrmed Arx binding to the HBS of SFPE2
(Fig. 3B).
The HBS and FoxA2 binding site in the SFPE2 are very near each
other (approximately 50 bp apart) and FoxA2 is known to interact
with other homeodomain transcription factors (Foucher et al.,
2003; Rausa et al., 2003). This raised the possibility that Arx might
physically interact with FoxA2. To test this possibility, we per-
formed the immunoprecipitation experiment using HEK293 cells,
which were co-transfected with FLAG-FoxA2 and Arx-Myc. Arx was
co-immunoprecipitated with FoxA2, conﬁrming an interaction
between Arx and FoxA2 (Fig. 3C). We further investigated which
domain of Arx can interact with FoxA2, using a series of Arx
deletion constructs, each fused with Gal4DB for nuclear targeting.
A construct containing the homeodomain, Gal4DB-321-470, was
co-immunoprecipitated with FoxA2, whereas constructs that did
not contain the homeodomain were not co-immunoprecipitated
(Fig. 3D). These data indicate that the Arx homeodomain is
required for an interaction with FoxA2. Taken together, our data
support a model where Arx binds to the HBS sequence in SFPE2
and interacts with FoxA2, which binds to an adjacent site in SFPE2,
to directly induce Shh expression. We postulate the interaction
with FoxA2 for Shh induction is cooperative.
The transcriptional activation domain (aristaless domain) of Arx is
required for Shh induction
Arx is known to function both as a transcriptional repressor
and activator (Colasante et al., 2009; Collombat et al., 2003;
Fullenkamp and El-Hodiri, 2008; Fulp et al., 2008; McKenzie
et al., 2007). It contains two strong repression domains (one in
the octapeptide domain at the N-terminal and the other in the
region, aa400–495) and one activation domain, the aristaless
domain at the C-terminus (McKenzie et al., 2007). Recent studies
indicate Arx functions predominantly as a transcriptional repres-
sor (Colasante et al., 2009; Collombat et al., 2003; Fulp et al., 2008;
Quille et al., 2011). The octapeptide domain has been shown to
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bind to Groucho/transducing-like enhancer of split (TLE) cofactor,
and repress transcription (McKenzie et al., 2007). How Arx func-
tions as a transcriptional activator, however, is poorly understood.
To determine whether the repression or the putative activation
domain of Arx is crucial for Shh induction, we generated three Arx
deletion constructs lacking the octapeptide domains for transcrip-
tional repression (Arx 61-564 and Arx 220-564) and one lacking
the C-terminal aristaless domain for transcriptional activation (Arx
1-470). All three mutants are expected to bind DNA and interact
with FoxA2 since the homeodomain, which binds DNA, and the
FoxA2 binding motif remains intact. These were independently co-
electroporated with FoxA2 into the chick spinal cord (HH stages
10–12), and the expression of Nkx2.2, a downstream target gene of
Shh, was assayed. While deletion of the known N-terminal
repression domain (1–220 amino acids) did not affect Nkx2.2
expression, the Arx 1-470 construct, which lacks the C-terminal
aristaless domain failed to induce Nkx2.2 cell non-autonomously
(Fig. 4). We believe the reason that Arx 220-564, with FoxA2, can
better induce Nkx2.2 result from the loss of the repression domain
in Arx. These data suggest that the C-terminal aristaless domain
for the activation is required to induce Shh expression.
Shh expression is diminished in the spinal cord of Arx-deﬁcient mice
Given our gain-of-function data in the chick embryo revealing
Arx as a positive regulator of Shh induction, we next asked
whether the endogenous loss of Arx would lead to a reduction in
Shh expression and signaling. To test this, we examined the
expressions of Shh and its downstream targets in the spinal cord
of Arx /y mice. The intensity and overall area of Shh
immunostaining in the FP of Arx /y (E10.5) mice were reduced
when compared to control littermates (Fig. 5A). Although the
change was rather mild, Shh level in the FP relative to that in the
notochord was clearly reduced along the entire spinal cord in
Arx /y mice compared to control (0.5 in Arxþ /y; 0.43 in Arx /y)
(n¼3 mice). Similarly, the expression of FoxA2 and Alcam (another
FP marker; Schubert and Kaprielian, 2001) in the ventral spinal
cord was all reduced (Fig. 5A and Supplementary Fig. 1). These
changes in gene expression level during early development
persisted through later stages as shown with Olig2 (another Shh
induced gene) immunostaining. Fewer Olig2 positive cells were
detected in mutant spinal cords examined at E11.5 (labeling motor
neuron; Roelink et al., 1994)and at E14.5 (labeling oligodendro-
cytes; Ligon et al., 2006; Rowitch, 2004) (Fig. 5B). Notably, despite
reduced levels of Nkx2.2 and FoxA2, likely due to reduction in Shh
expression, we observed no change or expansion in the extent of
the Nkx2.2 domain to the FP (Supplementary Fig. 1), suggesting
that Arx does not repress Nkx2.2 expression. These data in Arx
mutant mice are consistent with our ﬁndings in chick.
FoxA2 can induce Arx expression
We next sought to determine how Arx expression was regu-
lated in the FP. We introduced the constitutively active Shh
receptor, SmoM2 (Xie et al., 1998), to the chick spinal cord (HH
stages 10–12) by electroporation and examined the effect of
ectopically induced Shh signaling. No induction of Arx was
observed, while the known Shh target genes, Nkx6.1, Nkx2.2, and
FoxA2, were ectopically induced (Fig. 6A). Next we electroporated
the mutant Gli3 lacking its N-terminal repressor domain (ΔN-
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Gli3) (Lei et al., 2004), which should act as an activator of Shh
signaling (Fig. 6B). ΔN-Gli3 disrupted neural tube structure on the
electroporated side, suggesting that its effect is stronger than that
of SmoM2, which did not affect neural tube morphology. None-
theless, consistent with the SmoM2 result, forced expression of
ΔN-Gli3 also did not induce Arx, while it successfully induced
Nkx6.1, Isl2, and FoxA2 in cell-autonomous manner (Fig. 6B).
Together, our data suggest that Shh signaling does not induce
Arx in the FP.
We next set out to examine the role of FoxA2 in Arx induction.
FoxA2 has been previously reported to induce Arx (Ribes et al.,
2010). We conﬁrmed that electroporation of a FoxA2 expression
construct into the chick spinal cord induced Arx cell autono-
mously, as well as Nkx2.2, Nkx6.1 and Shh (Fig. 6C and 7).
Furthermore, co-electroporation of FoxA2 with either Ptch1Δloop2
or Gli3 in the chick spinal cord conﬁrmed that FoxA2 induces Arx
expression even when Shh signaling is blocked (Supplementary
Fig 2). FoxA2 harbors both transcription activation and repression
domains (Costa and Grayson, 1991; Qian and Costa, 1995; Rausa
et al., 2003). Whether Arx induction by FoxA2 is mediated by its
activation domain, or repression domain, is currently unknown.
To determine which domain is responsible for Arx induction, we
electroporated mutant FoxA2 constructs lacking either the activa-
tion or the repression domain. Forced expression of FoxA2 mutant
construct lacking the activation domain (FoxA2ΔA) failed to induce
Arx expression, whereas a construct lacking the repression domain
(FoxA2ΔR) still induced Arx expression (Fig. 7). These results
indicate that FoxA2 transcription activation domain is required
for Arx induction.
Nkx2.2 can repress Arx expression
The fact that Shh induces FoxA2 and FoxA2 induces Arx
expression, but Shh could not induce Arx, seemed incongruent.
A further understanding of this apparent contradiction came
through our observation of the functional relationships between
Arx and Nkx2.2 (a Shh induced gene). Forced expression of FoxA2
can induce Nkx2.2 non-cell autonomously, while it induces Arx
cell autonomously (Supplementary Fig. 3) (Ribes et al., 2010).
Conversely, forced expression of Nkx2.2 induced FoxA2 expression
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(Fig. 8A; top left rows). Interestingly, this ectopic expression of
FoxA2 by Nkx2.2 electroporation did not induce Arx (Fig. 8A; top
right rows). Two possible explanations for this observation (1) the
FoxA2 levels induced by Nkx2.2 electroporation are not sufﬁcient
to induce Arx, or (2) Nkx2.2 might inhibit Arx induction. To
distinguish these possibilities, we electroporated FoxA2 together
with Nkx2.2 (DNA amount 1:1) to provide sufﬁcient FoxA2 levels,
but again did not detect Arx induction. This result suggests that
the induction of Arx is not dependent on the level of FoxA2
expression. To determine if Nkx2.2 can repress Arx induction, we
generated mutant form of Nkx2.2 that contains the homeodomain
only (Nkx2.2HD), lacking the known transcriptional repression
domain for co-electroporation with FoxA2 (Muhr et al., 2001;
Watada et al., 2000). Furthermore, the repression domain in
Nkx2.2 is required for Shh induction through a gene regulatory
network. Nkx2.2 induces Shh, and therefore FoxA2, by repressing
Pax6. Pax6 induces the Shh repressor Gli3 and thus Nkx2.2
induces Shh by repressing the expression of Gli3 (Lek et al.,
2010). As we expected, the Nkx2.2HD mutant does not induce
FoxA2 due to the loss of Nkx2.2 repression domain (Supple-
mentary Fig. 4). Surprisingly, the FoxA2-induced Arx expression
was no longer abolished when the Nkx2.2HD was used for FoxA2
co-electroporation, demonstrating that Nkx2.2 transcription
repression function is required for abolishing FoxA2-induced Arx
expression (Fig. 8A; bottom rows). Based on these observations,
we argue that the reason Shh signaling does not induce Arx,
despite the fact that it can induce FoxA2, is due to the Nkx2.2
related repression of Arx. This is consistent with the fact that Arx is
not expressed in the early FP where Nkx2.2 is present, but only
expressed in the later FP when Nkx2.2 is no longer expressed.
Further evidence to support this mechanism is found in the results
of our experiments ectopically expressing FoxA2. Arx and Nkx2.2
expression was always mutually exclusive (Supplementary Fig. 3).
These data are similar to the mechanistic role Arx plays in
pancreatic beta-cell. Nkx2.2 represses Arx in these cells to main-
tain beta cell identity. This repression is achieved through the
recruitment of repression complex including Grg3, HDAC1 and
DNMT3 (Papizan et al., 2012). We believe a similar repression
mechanism may play a role in spinal cord FP cell speciﬁcation.
Interestingly, when SmoM2 or ΔN-Gli3 (activators of Shh
signaling) was co-electroporated with FoxA2, they do not abolish
FoxA2-induced Arx expression (Fig. 8B), suggesting that activated
Shh signaling does not directly repress Arx induction. However,
SmoM2 or ΔN-Gli3 can ectopically induce Nkx2.2, and Nkx2.2
positive cells do not express Arx (Fig. 8B), supporting our ﬁnding
that Nkx2.2 represses FoxA2-induced Arx expression.
Discussion
Shh plays a critical role in spinal cord development as a
morphogen for orchestrating cell type speciﬁcation and mainte-
nance, along with also functioning as a chemoattractant for
commissural axon guidance (Bourikas et al., 2005; Dessaud et al.,
2008). To serve these functions for normal spinal cord develop-
ment, Shh expression requires tight spatial and temporal regula-
tion. Although the function of Shh in spinal cord development has
been intensively studied, the regulation of Shh expression in the FP
is incompletely understood. To our knowledge, FoxA2 is the only
known transcription factor shown to directly bind to one of the
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Shh enhancers and activate its expression in the spinal cord (Jeong
and Epstein, 2003). Here we show that another transcription
factor, Arx, in collaboration with FoxA2, directly induces Shh
expression. It binds to the homeobox element, which is located
adjacent to FoxA2 binding site of the Shh FP enhancer (SFPE2) that
drives FP speciﬁc expression in the spinal cord. Our data support a
model wherein Arx and FoxA2 physically interact while binding at
the SFPE2 element and this cooperative binding regulates Shh
transcription. Furthermore, FoxA2 induces Arx and this induction
is repressed by Nkx2.2, suggesting that a complex feedback loop
exists between FoxA2, Arx and Shh signaling (Fig. 9).
Arx collaborates with FoxA2 to regulate Shh expression in the ﬂoor
plate
Shh expression along the anteroposterior axis of the mouse
central nervous system is regulated by multiple enhancers. To date
six enhancers distributed over 400 kb, both upstream and down-
stream of the transcription initiation site, have been identiﬁed
(Epstein et al., 1999; Jeong et al., 2006; Jeong and Epstein, 2003).
Among these six enhancers, two Shh FP-speciﬁc enhancers, SFPE1
and SFPE2, are known to regulate Shh expression in the spinal
cord. While SFPE1 is sufﬁcient for directing Shh expression in the
FP, SFPE2 works cooperatively with another enhancer, Shh brain
enhancer 1 (SBE1), for its FP speciﬁc enhancer function. SFPE2 and
SBE1 are intronic enhancers located adjacent to each other and
within intron 2 of the Shh gene. Comparative sequence analysis
among different species identiﬁed four highly conserved sequence
elements (transcription factor binding sites) within SFPE2: homeo-
box transcription factor binding site (HBS), Foxh1 binding site, T-
box binding site, and FoxA binding site. Further functional analysis
in mice revealed that the HBS is required for driving Shh expres-
sion in the FP of the spinal cord and the FoxA binding site directs
expression in the FP and notochord. In contrast, the Foxh1 binding
site appears unnecessary and the T-box binding site drives
repression. Interestingly, either HBS or FoxA binding site is not
sufﬁcient for SFPE2 activity on their own, but cooperative inter-
action is required between these two sites (Jeong and Epstein,
2003). No homeodomain protein has previously been identiﬁed
that could bind to this HBS. Nkx2 or Nkx6 family members were
considered candidates (Jeong and Epstein, 2003); however mem-
bers of these families are not expressed in the FP when Shh gene is
induced and thus are not considered good candidates. Our data in
this study identiﬁes Arx as the homeodomain transcription factor
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G. Cho et al. / Developmental Biology 393 (2014) 137–148146
that binds to this HBS of the SFPE2, and in collaboration with
FoxA2 regulates Shh gene expression in the spinal cord FP.
Considering the importance of Shh function in the spinal cord
development, it is not surprising to ﬁnd multiple and complex
regulatory controls to direct and maintain precise levels of Shh
expression. Since Shh expression in the ventral spinal cord is
regulated by more than one enhancer, and SFPE1 (FoxA2 or Arx
independent) alone is sufﬁcient for Shh expression in the FP
(Epstein et al., 1999); it is not surprising to observe only minimal
changes in Shh expression in the Arx-deﬁcient mice. In fact, even
mild changes in Shh and downstream signaling in Arx-deﬁcient
mice suggest a signiﬁcant involvement of Arx in a regulatory
network of Shh expression. One sensitive measure of Shh signaling
is to examine the downstream cell types generated by speciﬁc Shh
concentrations, such as motor neuron- and oligodendrocyte pro-
genitors (Allen et al., 2011, 2007; Dessaud et al., 2010; Ericson et
al., 1996; Yu et al., 2013). Our data showing a mild reduction in
motor neurons and oligodendrocytes (Olig2 positive cells) in Arx-
deﬁcient mice provides further evidence that loss of Arx is
responsible for a perturbation in Shh signaling.
Arx is part of a complex gene regulatory network controlling the
expression of intrinsic as well as extrinsic factors of the ﬂoor plate
development
The FP speciﬁcation involves the interplay between extrinsic
signaling molecule, Shh, and intrinsic transcription factors such as
FoxA2. Initially, Shh from the notochord can induce FoxA2 expres-
sion in the FP, and FoxA2 in turn induces Shh expression in the FP.
Although the initial speciﬁcation of the FP requires Shh signaling,
the maintenance of the FP identity becomes no longer dependent
on its signaling, as Ptch1, Hhip, Gli1, Gli3 and Nkx2.2 are directly or
indirectly repressed by FP FoxA2 or GliR (Metzakopian et al.,
2012; Peterson et al., 2012; Vokes et al., 2007), which results in
attenuation of Shh signaling. While the FP cells down regulate Shh
signaling to maintain their identity, Shh expression itself does not
decrease in the FP, which can ensure enough production and
secretion of Shh for the speciﬁcation of adjacent cell populations
such as V3 neurons and motor neurons from the p3 and pMN
domains, respectively. Thus, it is important to understand how Shh
expression can be maintained in the FP while Shh signaling is
down regulated.
Our studies add Arx to the network of known transcription
factors regulating and maintaining Shh expression in the FP.
Conversely, whether Shh signaling can regulate Arx expression or
not turns out to be a little more complicated. Our data show that
activated Shh signaling, via SmoM2 or ΔN-Gli3 electroporation in
the neural tube, does not induce Arx (Fig. 6). These results seem
inconsistent with the previous report documenting Arx induction
by Shh treatment in the naive neural plate explants (Ribes et al.,
2010). This discrepancy suggests that the induction of Arx by Shh
might have a temporal restriction. It is possible that at earlier stage
(neural plate stage), Shh can induce Arx because Nkx2.2, which
can repress Arx, is not present yet due to the absence of Sox2
which is necessary for induction of Nkx2.2 (Peterson et al., 2012).
At a later stage (neural tube stage, which was used in our study),
however, Shh signaling does not induce Arx since Nkx2.2 is
available to repress Arx induction, as we showed in this study.
In summary, our studies have extended our understanding of
the complex gene regulatory network involving intrinsic and
extrinsic factors in FP development. We have provided evidence
that Arx is a cooperating transcription factor with FoxA2 for Shh
expression in the FP and that loss of Arx results in mild but
signiﬁcant decrease in Shh and Shh signaling. Our results suggest
that the transcriptional co-activation function of ARX might be a
key to understand the pathogenesis of human patients with ARX
mutations. Given that many phenotypes in these patients are
diverse and subtle, the result of this cooperative role of ARX in
gene induction rather than a unique and independent role,
provides a potential mechanistic insight into how this diverse
spectrum of phenotypes could be observed.
Acknowledgments
We thank Dr. M.P. Matise (Rutgers University) for Ptch1Δloop2,
SmoM2 and ΔN-Gli3 expression constructs and Dr. D. Epstein
(University of Pennsylvania) for the discussion. This work was
supported by NIH Grant NS46616.
Appendix A. Supplementary information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.06.012.
References
Allen, B.L., Song, J.Y., Izzi, L., Althaus, I.W., Kang, J.-S., Charron, F., Krauss, R.S.,
McMahon, A.P., 2011. Overlapping roles and collective requirement for the
coreceptors GAS1, CDO, and BOC in SHH pathway function. Dev. Cell 20,
775–787.
Allen, B.L., Tenzen, T., McMahon, A.P., 2007. The hedgehog-binding proteins Gas1
and Cdo cooperate to positively regulate Shh signaling during mouse develop-
ment. Genes Dev. 21, 1244–1257.
Balaskas, N., Ribeiro, A., Panovska, J., Dessaud, E., Sasai, N., Page, K.M., Briscoe, J.,
Ribes, V., 2012. Gene regulatory logic for reading the sonic hedgehog signaling
gradient in the vertebrate neural tube. Cell 148, 273–284.
Bourikas, D., Pekarik, V., Baeriswyl, T., Grunditz, A., Sadhu, R., Nardó, M., Stoeckli, E.
T., 2005. Sonic hedgehog guides commissural axons along the longitudinal axis
of the spinal cord. Nat. Neurosci. 8, 297–304.
Briscoe, J., Pierani, A., Jessell, T.M., Ericson, J., 2000. A homeodomain protein code
speciﬁes progenitor cell identity and neuronal fate in the ventral neural tube.
Cell 101, 435–445.
Chamberlain, C.E., Jeong, J., Guo, C., Allen, B.L., McMahon, A.P., 2008. Notochord-
derived Shh concentrates in close association with the apically positioned basal
body in neural target cells and forms a dynamic gradient during neural
patterning. Development 135, 1097–1106.
Cho, G., Nasrallah, M.P., Lim, Y., Golden, J.A., 2012. Distinct DNA binding and
transcriptional repression characteristics related to different ARX mutations.
Neurogenetics 13, 23–29.
Colasante, G., Sessa, A., Crispi, S., Calogero, R., Mansouri, A., Collombat, P., Broccoli,
V., 2009. Arx acts as a regional key selector gene in the ventral telencephalon
mainly through its transcriptional repression activity. Dev. Biol. 334, 59–71.
Colasante, G., Simonet, J.C., Calogero, R., Crispi, S., Sessa, A., Cho, G., Golden, J.A.,
Broccoli, V., 2013. ARX regulates cortical intermediate progenitor cell expansion
and upper layer neuron formation through repression of Cdkn1c. Cereb. Cortex
2013 (Epub ahead of print).
Collombat, P., Mansouri, A., Hecksher-Sorensen, J., Serup, P., Krull, J., Gradwohl, G.,
Gruss, P., 2003. Opposing actions of Arx and Pax4 in endocrine pancreas
development. Genes Dev. 17, 2591–2603.
Colombo, E., Galli, R., Cossu, G., Gecz, J., Broccoli, V., 2004. Mouse orthologue of
ARX, a gene mutated in several X-linked forms of mental retardation and
epilepsy, is a marker of adult neural stem cells and forebrain GABAergic
neurons. Dev. Dyn. 231, 631–639.
Costa, R.H., Grayson, D.R., 1991. Site-directed mutagenesis of hepatocyte nuclear
factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal
synergistic interactions with its enhancer region. Nucleic Acids Res. 19,
4139–4145.
Davidson, E.H., 2002. A genomic regulatory network for development. Science 295,
1669–1678.
Dessaud, E., McMahon, A.P., Briscoe, J., 2008. Pattern formation in the vertebrate
neural tube: a sonic hedgehog morphogen-regulated transcriptional network.
Development 135, 2489–2503.
Dessaud, E., Ribes, V., Balaskas, N., Yang, L.L., Pierani, A., Kicheva, A., Novitch, B.G.,
Briscoe, J., Sasai, N., 2010. Dynamic assignment and maintenance of positional
identity in the ventral neural tube by the morphogen sonic hedgehog. PLoS
Biol. 8, e1000382.
Dessaud, E., Yang, L.L., Hill, K., Cox, B., Ulloa, F., Ribeiro, A., Mynett, A., Novitch, B.G.,
Briscoe, J., 2007. Interpretation of the sonic hedgehog morphogen gradient by a
temporal adaptation mechanism. Nature 450, 717–720.
Epstein, D.J., McMahon, A.P., Joyner, A.L., 1999. Regionalization of sonic hedgehog
transcription along the anteroposterior axis of the mouse central nervous
system is regulated by Hnf3-dependent and -independent mechanisms. Devel-
opment 126, 281–292.
G. Cho et al. / Developmental Biology 393 (2014) 137–148 147
Ericson, J., Morton, S., Kawakami, A., Roelink, H., Jessell, T.M., 1996. Two critical
periods of sonic hedgehog signaling required for the speciﬁcation of motor
neuron identity. Cell 87, 661–673.
Foucher, I., Montesinos, M.L., Volovitch, M., Prochiantz, A., Trembleau, A., 2003.
Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and engrailed is
the result of a highly conserved mechanism for direct interaction of homeo-
proteins and Fox transcription factors. Development 130, 1867–1876.
Friocourt, G., Parnavelas, J.G., 2010. Mutations in ARX result in several defects
involving GABAergic neurons. Front. Cell. Neurosci. 4, 4.
Fullenkamp, A.N., El-Hodiri, H.M., 2008. The function of the Aristaless-related
homeobox (Arx) gene product as a transcriptional repressor is diminished by
mutations associated with X-linked mental retardation (XLMR). Biochem.
Biophys. Res. Commun. 377, 73–78.
Fulp, C.T., Cho, G., Marsh, E.D., Nasrallah, I.M., Labosky, P.A., Golden, J.A., 2008.
Identiﬁcation of Arx transcriptional targets in the developing basal forebrain.
Hum. Mol. Genet. 17, 3740–3760.
Jeong, Y., El-Jaick, K., Roessler, E., Muenke, M., Epstein, D.J., 2006. A functional
screen for sonic hedgehog regulatory elements across a 1 Mb interval identiﬁes
long-range ventral forebrain enhancers. Development 133, 761–772.
Jeong, Y., Epstein, D.J., 2003. Distinct regulators of Shh transcription in the ﬂoor
plate and notochord indicate separate origins for these tissues in the mouse
node. Development 130, 3891–3902.
Jessell, T.M., 2000. Neuronal speciﬁcation in the spinal cord: inductive signals and
transcriptional codes. Nat. Rev. Genet. 1, 20–29.
Kato, M., Das, S., Petras, K., Kitamura, K., Morohashi, K.-I., Abuelo, D.N., Barr, M.,
Bonneau, D., Brady, A.F., Carpenter, N.J., Cipero, K.L., Frisone, F., Fukuda, T.,
Guerrini, R., Iida, E., Itoh, M., Lewanda, A.F., Nanba, Y., Oka, A., Proud, V.K.,
Saugier-Veber, P., Schelley, S.L., Selicorni, A., Shaner, R., Silengo, M., Stewart, F.,
Sugiyama, N., Toyama, J., Toutain, A., Vargas, A.L., Yanazawa, M., Zackai, E.H.,
Dobyns, W.B., 2004. Mutations of ARX are associated with striking
pleiotropy and consistent genotype–phenotype correlation. Hum. Mutat. 23,
147–159.
Kitamura, K., Yanazawa, M., Sugiyama, N., Miura, H., Iizuka-Kogo, A., Kusaka, M.,
Omichi, K., Suzuki, R., Kato-Fukui, Y., Kamiirisa, K., Matsuo, M., Kamijo, S.-I.,
Kasahara, M., Yoshioka, H., Ogata, T., Fukuda, T., Kondo, I., Kato, M., Dobyns, W.
B., Yokoyama, M., Morohashi, K.-I., 2002. Mutation of ARX causes abnormal
development of forebrain and testes in mice and X-linked lissencephaly with
abnormal genitalia in humans. Nat. Genet. 32, 359–369.
Lei, Q., Zelman, A.K., Kuang, E., Li, S., Matise, M.P., 2004. Transduction of graded
hedgehog signaling by a combination of Gli2 and Gli3 activator functions in the
developing spinal cord. Development 131, 3593–3604.
Lek, M., Dias, J.M., Marklund, U., Uhde, C.W., Kurdija, S., Lei, Q., Sussel, L.,
Rubenstein, J.L., Matise, M.P., Arnold, H.-H., Jessell, T.M., Ericson, J., 2010. A
homeodomain feedback circuit underlies step-function interpretation of a Shh
morphogen gradient during ventral neural patterning. Development 137,
4051–4060.
Ligon, K.L., Fancy, S.P.J., Franklin, R.J.M., Rowitch, D.H., 2006. Olig gene function in
CNS development and disease. Glia 54, 1–10.
Lim, Y., Cho, G., Minarcik, J., Golden, J., 2005. Altered BMP signaling disrupts chick
diencephalic development. Mech. Dev. 122, 603–620.
Marsh, E., Fulp, C., Gomez, E., Nasrallah, I., Minarcik, J., Sudi, J., Christian, S.L.,
Mancini, G., Labosky, P., Dobyns, W., Brooks-Kayal, A., Golden, J.A., 2009.
Targeted loss of Arx results in a developmental epilepsy mouse model and
recapitulates the human phenotype in heterozygous females. Brain 132,
1563–1576.
McKenzie, O., Ponte, I., Mangelsdorf, M., Finnis, M., Colasante, G., Shoubridge, C.,
Stifani, S., Gécz, J., Broccoli, V., 2007. Aristaless-related homeobox gene, the
gene responsible for West syndrome and related disorders, is a Groucho/
transducin-like enhancer of split dependent transcriptional repressor. Neu-
roscience 146, 236–247.
Megason, S.G., McMahon, A.P., 2002. A mitogen gradient of dorsal midline Wnts
organizes growth in the CNS. Development 129, 2087–2098.
Metzakopian, E., Lin, W., Salmon-Divon, M., Dvinge, H., Andersson, E., Ericson, J.,
Perlmann, T., Whitsett, J.A., Bertone, P., Ang, S.L., 2012. Genome-wide char-
acterization of Foxa2 targets reveals upregulation of ﬂoor plate genes and
repression of ventrolateral genes in midbrain dopaminergic progenitors.
Development 139, 2625–2634.
Mégarbané, A., Chouery, E., Mignon-Ravix, C., Sabbagh El, S., Corbani, S., Ghoch, J.A.,
Jalkh, N., Mehawej, C., Lévy, N., Villard, L., 2011. Ambiguous genitalia, micro-
cephaly, seizures, bone malformations, and early death: a distinct MCA/MR
syndrome. Am. J. Med. Genet. A 155A, 1147–1151.
Miura, H., Yanazawa, M., Kato, K., Kitamura, K., 1997. Expression of a novel aristaless
related homeobox gene “Arx” in the vertebrate telencephalon, diencephalon
and ﬂoor plate. Mech. Dev. 65, 99–109.
Muhr, J., Andersson, E., Persson, M., Jessell, T.M., Ericson, J., 2001. Groucho-
mediated transcriptional repression establishes progenitor cell pattern and
neuronal fate in the ventral neural tube. Cell 104, 861–873.
Nasrallah, M.P., Cho, G., Putt, M.E., Kitamura, K., Golden, J.A., 2012. Differential
effects of a polyalanine tract expansion in Arx on neural development and gene
expression. Hum. Mol. Genet. 21, 1090–1098.
Olivetti, P.R., Noebels, J.L., 2012. Interneuron, interrupted: molecular pathogenesis
of ARX mutations and X-linked infantile spasms. Curr. Opin. Neurobiol. 22,
859–865.
Oosterveen, T., Kurdija, S., Alekseenko, Z., Uhde, C.W., Bergsland, M., Sandberg, M.,
Andersson, E., Dias, J.M., Muhr, J., Ericson, J., 2012. Mechanistic differences in
the transcriptional interpretation of local and long-range Shh morphogen
signaling. Dev. Cell 23, 1006–1019.
Pani, L., Overdier, D.G., Porcella, A., Qian, X., Lai, E., Costa, R.H., 1992. Hepatocyte
nuclear factor 3 beta contains two transcriptional activation domains, one of
which is novel and conserved with the Drosophila fork head protein. Mol. Cell.
Biol. 12, 3723–3732.
Papizan, J.B., Singer, R.A., Tschen, S., Dhawan, S., Friel, J.M., Hipkens, S.B., Magnuson,
M.A., Bhushan, A., Sussel, L., 2012. Nkx2.2 repressor complex regulates islet β
-cell speciﬁcation and prevents β-to-α-cell reprogramming. Genes Dev. 25,
2291–2305.
Peterson, K.A., Nishi, Y., Ma, W., Vedenko, A., Shokri, L., Zhang, X., McFarlane, M.,
Baizabal, J.-M., Junker, J.P., van Oudenaarden, A., Mikkelsen, T., Bernstein, B.E.,
Bailey, T.L., Bulyk, M.L., Wong, W.H., McMahon, A.P., 2012. Neural-speciﬁc
Sox2 input and differential Gli-binding afﬁnity provide context and posi-
tional information in Shh-directed neural patterning. Genes Dev. 26,
2802–2816.
Qian, X., Costa, R.H., 1995. Analysis of hepatocyte nuclear factor-3 beta protein
domains required for transcriptional activation and nuclear targeting. Nucleic
Acids Res. 23, 1184–1191.
Quille, M.-L., Carat, S., Quéméner-Redon, S., Hirchaud, E., Baron, D., Benech, C.,
Guihot, J., Placet, M., Mignen, O., Férec, C., Houlgatte, R., Friocourt, G., 2011.
High-throughput analysis of promoter occupancy reveals new targets for Arx, a
gene mutated in mental retardation and interneuronopathies. PLoS One 6,
e25181.
Rausa, F.M., Tan, Y., Costa, R.H., 2003. Association between hepatocyte nuclear
factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcrip-
tional activity but inhibits HNF-6 DNA binding. Mol. Cell. Biol. 23, 437–449.
Ribes, V., Balaskas, N., Sasai, N., Cruz, C., Dessaud, E., Cayuso, J., Tozer, S., Yang, L.L.,
Novitch, B., Marti, E., Briscoe, J., 2010. Distinct sonic hedgehog signaling
dynamics specify ﬂoor plate and ventral neuronal progenitors in the vertebrate
neural tube. Genes Dev. 24, 1186–1200.
Roelink, H., Augsburger, A., Heemskerk, J., Korzh, V., Norlin, S., Ruiz i Altaba, A.,
Tanabe, Y., Placzek, M., Edlund, T., Jessell, T.M., 1994. Floor plate and motor
neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the
notochord. Cell 76, 761–775.
Rowitch, D.H., 2004. Glial speciﬁcation in the vertebrate neural tube. Nat. Rev.
Neurosci. 5, 409–419.
Schubert, W., Kaprielian, Z., 2001. Identiﬁcation and characterization of a cell
surface marker for embryonic rat spinal accessory motor neurons. J. Comp.
Neurol. 439, 368–383.
Sherr, E.H., 2003. The ARX story (epilepsy, mental retardation, autism, and cerebral
malformations): one gene leads to many phenotypes. Curr. Opin. Pediatr. 15,
567–571.
Shoubridge, C., Fullston, T., Gecz, J., 2010. ARX spectrum disorders: making inroads
into the molecular pathology. Hum. Mutat. 31, 889–900.
Strømme, P., Mangelsdorf, M.E., Shaw, M.A., Lower, K.M., Lewis, S.M.E., Bruyere, H.,
Lütcherath, V., Gedeon, A.K., Wallace, R.H., Scheffer, I.E., Turner, G., Partington,
M., Frints, S.G.M., Fryns, J.-P., Sutherland, G.R., Mulley, J.C., Gecz, J., 2002.
Mutations in the human ortholog of Aristaless cause X-linked mental retarda-
tion and epilepsy. Nat. Genet. 30, 441–445.
Tenzen, T., Allen, B.L., Cole, F., Kang, J.-S., Krauss, R.S., McMahon, A.P., 2006. The cell
surface membrane proteins Cdo and Boc are components and targets of the
hedgehog signaling pathway and feedback network in mice. Dev. Cell 10,
647–656.
Vokes, S.A., Ji, H., McCuine, S., Tenzen, T., Giles, S., Zhong, S., Longabaugh, W.J.R.,
Davidson, E.H., Wong, W.H., McMahon, A.P., 2007. Genomic characterization of
Gli-activator targets in sonic hedgehog-mediated neural patterning. Develop-
ment 134, 1977–1989.
Wang, B., Fallon, J.F., Beachy, P.A., 2000. Hedgehog-regulated processing of Gli3
produces an anterior/posterior repressor gradient in the developing vertebrate
limb. Cell 100, 423–434.
Wang, J.C., Waltner-Law, M., Yamada, K., Osawa, H., Stifani, S., Granner, D.K., 2000.
Transducin-like enhancer of split proteins, the human homologs of Drosophila
groucho, interact with hepatic nuclear factor 3beta. J. Biol. Chem. 275,
18418–18423.
Watada, H., Mirmira, R.G., Kalamaras, J., German, M.S., 2000. Intramolecular control
of transcriptional activity by the NK2-speciﬁc domain in NK-2 homeodomain
proteins. Proc. Natl. Acad. Sci. USA 97, 9443–9448.
Xie, J., Murone, M., Luoh, S.M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J.M., Lam, C.W.,
Hynes, M., Goddard, A., Rosenthal, A., Epstein, E.H., de Sauvage, F.J., 1998.
Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391,
90–92.
Yu, Y., Chen, Y., Kim, B., Wang, H., Zhao, C., He, X., Liu, L., Liu, W., Wu, L.M.N., Mao,
M., Chan, J.R., Wu, J., Lu, Q.R., 2013. Olig2 targets chromatin remodelers to
enhancers to initiate oligodendrocyte differentiation. Cell 152, 248–261.
G. Cho et al. / Developmental Biology 393 (2014) 137–148148
